Cost effectiveness of concurrent chemoradiation in comparison with radiation alone in locally advanced cervical cancer

Journal of the Medical Association of Thailand

Volumn 88, Issue 8, 2005, Pages 1035-1044

  Manusirivithaya, Sumonmal ^a   Sripramote, Manit ^a   Tangjitgamol, Siriwan ^a   Sanjareonsuttikul, Nopawan ^b   Pisarnturakit, Pagaporn ^c  

^a NAVAMINDRADHIRAJ UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Cervical cancer; Chemoradiation; Cost effectiveness; Cost utility; Radiation

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADVANCED CANCER; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DECISION THEORY; FEBRILE NEUTROPENIA; FOLLOW UP; HUMAN; NEUTROPENIA; TUMOR GROWTH; TUMOR RECURRENCE; UTERINE CERVIX CANCER;

AMBULATORY CARE; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; COST-BENEFIT ANALYSIS; DECISION TREES; DIRECT SERVICE COSTS; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; QUALITY-ADJUSTED LIFE YEARS; RECURRENCE; THAILAND; UTERINE CERVICAL NEOPLASMS;

EID: 26244440551     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Deerasamee S, Martin N, Sontipong S, Sriamporn S, Sirplung H, Srivatanakul P, et al. Cancer in Thaliland. IARC technical report No 34, 1999: 56.
2. Maunsirivithaya S. Gynecologic Oncology Annual Report: BMA Medical College and Vajira Hospital; 2001. Report No 3.
3. Maleemonkol S, Charoeniam V, Isariyodom P, Pantusart A. Risk factors for pelvic node metastasis in cervical cancer patients undergoing radical hysterectomy and pelvic lymphadenectomy. Chiang Mai Med Bull 1995; 34: 167-71.
4. Martimbeau P, Kijorstad K, Iversen T. State Ib carcinoma of the cervix,The Norwegia Radium Hospital II. Results when pelic nodes are involved. Obstet Gynecol 1982; 60: 215-8.
5. Morris M, Eifel P, Lu J, Grigsby P, Levenback C, Stevens R, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and paraaortic radiation for high-risk cervical cancer. N Engl J Med 1999; 340: 1137-43.
6. Rose P, Bundy B, Watkin E, Thigpen T, Deppe G, Maiman M, et al. Concurrent cisplatim-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999; 340: 1144-53.
7. Keys H, Bundy B, Stehman F, Muderspach L, Chafe W, Suggs C III, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999; 340: 1154-61.
8. Pearcey R, Brundage M, Drouin P, Jeffrey J, Johnstom D, Lukka K, et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol 2002; 20: 966-72.
9. Whitney C, Sause W, Bundy B, Malfetamo J, Hannigan E, Fowler W, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group Study. J Clin Oncol 1999; 17: 1339-48.
10. Peters III W, Liu P, Barrett II R, Stock R, Monk B, Berek J, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation theapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000; 18: 1606-13.
11. Thomas GM. Improved treatment for cervical cancer: concurrent chemotherapy and radiotherapy. N Engl J Med 1999; 340: 1198-200.
12. Green J, Kirwan J, Tierney J, Symonds P, Fresco L, Collingwood M, et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. The Cochrane Library 2002(1).
13. Green J, Kirwan J, Tierney J, Symonds P, Fresco L, Collingwood M, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix; a systematic review and meta-analysis. Lancet 2001; 358: 781-6.
14. Bodey F. Antibiotics in patients with neutropenia. Arch Intern Med 1984; 144: 1845-51.
15. Kamolrattanakul P, Srirattanabal J, Ngarmkieartpisarn S. Unit cost analysis of King Chulalongkorn Memorail Hospital. Research report; King Chulalongkorn Memorail Hospital 2002.
16. Sheanakul C, Manusirivithaya S, Tantiwattana T, Nakwong L. Results of invasive cervical cancer treatment at BMA Medical College and Vajira Hospital. Vajira Med J 2003; 46: 93-102.
17. Burke TW, Hoskins WJ, Heller PB, Shen MC, Weiser EB, Park RC. Clinical patterns of tumor recurrence after radical hysterectomy in stage IB cervical carcinoma. Obstet Gynecol 1987; 69: 382-5.
18. Alberts DS, Garcia DJ. Salvage chemotherapy in recurrent or refractory squamous cell cancer of the uterine cervix. Semin Oncol 1994; 21 (4 Suppl 7): 37-46.
19. Rose P, Lappas P. Analysis of the cost effectiveness of concurrent cisplatin-based chemoradiation in cervical cancer: implications from five randomized trials. Gynecol Oncol 2000; 78: 3-6.